Cizzle Brands Corporation (CBOE:CZZL)

Cizzle Brands: A Sports Nutrition Company Leading the Next Wave in Health and Wellness


Cizzle Brands (CBOE:CZZL) is a sports nutrition company driving transformative change within the health and wellness industry. The company commenced trading on CBOE Canada on December 30, 2024, marking a significant milestone in its growth trajectory.

Cizzle Brands leverages deep-rooted connections in the professional sports sector by collaborating with elite athletes to trial and refine health and wellness products to ensure optimal performance, while still being appropriate for athletes of all ages. The CWENCH Hydration products underscore its commitment to premium-quality offerings.

Cizzle Brand CWENCH Hydration products

Through Cizzle's broad-based grassroots programs, more than 12,000 youth athletes across North America are sponsored by Cizzle, featuring CWENCH logos on their helmets, jerseys and water bottles.

Company Highlights

  • Cizzle is dedicated to driving transformative change in the health and wellness industry by offering premium, clean-label sports nutrition products.
  • The companycollaborates with elite athletes and professional sports teams to trial and refine its product offerings, ensuring optimal performance.
  • Its flagship brand - CWENCH Hydration - is one of the fastest-growing hydration products in the world, with endorsements from top athletes like Nathan MacKinnon and Andrew Wiggins, as well as up-and-coming superstars Gavin McKenna and Chloe Primerano. Wiggins is also a significant investor in the business.
  • The company generated $5 million dollars in net sales in its first 6 months of operations with a gross margin of 60% and is projected to generate net sales of $13 to $15 million in its first fiscal year.
  • Driven by a well-defined growth strategy, the company is expanding distribution through major retailers, international market entry, and potential strategic acquisitions to drive revenue growth and market penetration.
  • Cizzle’s executive team has extensive experience in CPG, brand building and public markets, including former executives of BioSteel and DreamWater.

This Cizzle Brand Corporation profile is part of a paid investor education campaign.*

Click here to connect with Cizzle Brand (CBOE:CZZL) to receive an Investor Presentation

CZZL:AQL
Cizzle Brands Corporation

Cizzle Brands Corporation Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

The Conversation (0)
Cizzle Brands Corporation (CBOE:CZZL)

Cizzle Brands Corporation


Keep reading...Show less
Cizzle Brands Unveils its Team of Ambassadors to Accelerate North American Commercialization Initiatives

Cizzle Brands Unveils its Team of Ambassadors to Accelerate North American Commercialization Initiatives

Through a curated team of the world's most experienced and qualified dieticians, performance coaches, scientists, and medical professionals who are subject matter experts in their respective fields, Cizzle Brands is building a house of brands in the sports nutrition industry that serves the world's most elite athletes and leverages that knowledge to make products for everyday people looking to live healthy, active lifestyles. Cizzle Brands' ambassadors will not only assist in product development and formulation but they will also help to expand knowledge and adoption of Cizzle Brands' products around the world.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Don Saladino, Personal Trainer to Hollywood's A-List, Joins Cizzle Brands as an Advisor

Don Saladino, Personal Trainer to Hollywood's A-List, Joins Cizzle Brands as an Advisor

Hollywood actors, professional athletes, and award-winning musicians alike have all relied on Don Saladino, coach and trainer of over 20 years, to reach their full potential in physical fitness. As an advisor to Cizzle Brands, Mr. Saladino will provide his insights, expertise, and access to his vast professional network for the commercialization and promotion of Cizzle Brands' product lines at a global scale.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Cizzle Brands Corporation Teams up with Hockey Influencer, Coach Chippy, to launch Tropical Flow, a Special Edition Coach Chippy Inspired Flavour of CWENCH Hydration

Cizzle Brands Corporation Teams up with Hockey Influencer, Coach Chippy, to launch Tropical Flow, a Special Edition Coach Chippy Inspired Flavour of CWENCH Hydration

With a combined social media following of more than one million users, Coach Chippy is a leading influencer in youth hockey. Through his Tropical Flow flavour of CWENCH Hydration, which will be available for purchase at Pro Hockey Life, Source for Sports, Sports Excellence and other leading retailers, Coach Chippy will be creating greater visibility for CWENCH Hydration in a key demographic for the brand.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Test tubes.

Biotech Market Forecast: Top Trends for Biotech in 2025

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges.

The industry is being shaped by a confluence of factors, all of which are driving exciting innovations in healthcare.

Drawing from insights gained at the JP Morgan Healthcare Conference (JPMHC), held in San Francisco from January 13 to 16, the Investing News Network examines the key trends taking shape in biotech in 2025.

Keep reading...Show less

FDA APPROVES LUMAKRAS® IN COMBINATION WITH VECTIBIX® FOR CHEMOREFRACTORY KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER

Pivotal Study Demonstrated the Combination More Than Doubled Progression-Free Survival Compared to Investigated SOC

Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved LUMAKRAS ® (sotorasib) in combination with Vectibix ® (panitumumab) for the treatment of adult patients with KRAS G12C-mutated metastatic colorectal cancer (mCRC), as determined by an FDA-approved test, who have received prior fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy. Approval is based on the pivotal Phase 3 CodeBreaK 300 study, which demonstrated that LUMAKRAS plus Vectibix is the first and only targeted treatment combination for chemorefractory KRAS G12C-mutated mCRC to show superior progression-free survival (PFS) compared to the investigated standard-of-care (SOC). 1*

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

FDA APPROVES LUMAKRAS® IN COMBINATION WITH VECTIBIX® FOR CHEMOREFRACTORY KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER

Pivotal Study Demonstrated the Combination More Than Doubled Progression-Free Survival Compared to Investigated SOC

Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved LUMAKRAS ® (sotorasib) in combination with Vectibix ® (panitumumab) for the treatment of adult patients with KRAS G12C-mutated metastatic colorectal cancer (mCRC), as determined by an FDA-approved test, who have received prior fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy. Approval is based on the pivotal Phase 3 CodeBreaK 300 study, which demonstrated that LUMAKRAS plus Vectibix is the first and only targeted treatment combination for chemorefractory KRAS G12C-mutated mCRC to show superior progression-free survival (PFS) compared to the investigated standard-of-care (SOC). 1*

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare's Landmark Report

Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare's Landmark Report

Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is excited to announce that its cutting-edge anti-aging compound, TFC-1326, has been highlighted in Stonegate Healthcare Partners' latest research report. The publication, titled "Sirona Biochem's TFC-1326 Clinical Data Versus Retinoid Clinical Data," provides an extensive evaluation of TFC-1326's clinical trial performance, setting it apart from traditional retinoid treatments.

The report outlines the remarkable benefits of TFC-1326, including:

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Biotech therapy capsule containing DNA strand surrounded by cells.

Top 4 Canadian Biotech Stocks (Updated January 2025)

Biotech is a dynamic industry that is driving scientific advancements and innovation in healthcare. In Canada, the biotech industry is home to companies pursuing cutting-edge therapies and medical technologies.

According to Grandview Research, the global biotech market is expected to grow at a compound annual growth rate of 13.96 percent between 2024 and 2030 to reach a value of US$3.08 trillion.

Here, the Investing News Network profiles the five best-performing Canadian biotech stocks based on their year-on-year gains.

Keep reading...Show less
Cizzle Brands Launching Spoken Nutrition as its Latest Performance-Driven Brand for Athletes

Cizzle Brands Launching Spoken Nutrition as its Latest Performance-Driven Brand for Athletes

Spoken Nutrition™ is a premium brand of athlete-grade nutraceuticals that carry the prestigious NSF Certified for Sport® qualification, making Spoken products eligible for use by athletes in several major-league and minor-league organizations, as well as the NCAA. With purchase orders secured from many professional sports teams, including multiple MLB teams for use during Spring Training leading into the 2025 regular baseball season, the launch of Spoken Nutrition™ cements Cizzle Brands Corporation as a global leader in sports nutrition.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Cizzle Brands Corporation

Cizzle Brands Corporation Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

Latest Press Releases

Related News

×